Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Tocilizumab might be an effective treatment for COVID-19.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The treatment combination is effective and generally safe for lung cancer.

Pexidartinib often causes liver issues and fatigue, especially in women.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Certain drugs may cause vitiligo, so patients should be monitored.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Tislelizumab can cause cutaneous lupus erythematosus.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.